Just finished watching. I love this company. So Swami thinks as I do that they are still only scratching the surface of the demand for the product, especially in new countries like India and the Middle East. Of interest is the use of BTM in India that accelerated the enrolment of the BARDA trial. Swami says the data he's seen suggests it performed well in a market he wasn't confident about because of the incidence of infection. He says the results should give surgeons in the developing world confidence becuase if it works under the conditions in India, "it will work anywhere". The Indian market is very bureaucratic but they expect to get tender based orders coming through from individual hospitals this year, and they will be concentrating on 25 major burn centres although there are 600 potential hospitals. He also said that their BARDA trial data is "superb" and they expect to have FDA PMA approval completed in November 2025 which should help drive growth in FY2026. Suprathel was a dressing being sold through their distributor in Germany who they say is doing a great job selling Novosorb. So adding Suprathel to their lineup in Australasia is "returning a favour", but that they would also be looking at developing something that does the same job or better.
DW mentioned an anecdote about how many surgeons still have no idea that the product even exists and are being introduced to it by more knowledable colleagues.
So the implantable hernia products outperform existing products in animal trials, another future product that isn't really on the back burner.
So much to look forward to here. I think this is a stock that it's still reasonable to accumalate on weakness, any time Regal's bots manage to hound the price down.
- Forums
- ASX - By Stock
- Ann: FY24 Results Presentation
Just finished watching. I love this company. So Swami thinks as...
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.61 |
Change
-0.045(1.70%) |
Mkt cap ! $1.830B |
Open | High | Low | Value | Volume |
$2.60 | $2.63 | $2.59 | $480.6K | 184.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 8844 | $2.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.61 | 3797 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 2.610 |
9 | 35014 | 2.600 |
12 | 75899 | 2.590 |
7 | 23958 | 2.580 |
6 | 18848 | 2.570 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 76162 | 7 |
2.630 | 30574 | 7 |
2.640 | 30394 | 9 |
2.650 | 58434 | 11 |
2.660 | 45394 | 4 |
Last trade - 10.10am 02/10/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online